Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Center, Single-Dose, Double-Blind, Randomized, Two-Period, Crossover Study to Demonstrate Pharmacokinetic and Pharmacodynamic Similarity Between NKF-PEG, and US-Neulasta®, and to Evaluate Safety in Healthy Adult Male Volunteers

NCT07738991 is registered in ClinicalTrials.gov with Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT07738991
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07738991 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Center, Single-Dose, Double-Blind, Randomized, Two-Period, Crossover Study to Demonstrate Pharmacokinetic and Pharmacodynamic Similarity Between NKF-PEG, and US-Neulasta®, and to Evaluate Safety in Healthy Adult Male Volunteers
Lead sponsor
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
Phase
Phase 1
Overall status
Recruiting
Start date
July 3, 2026
Completion date
April 12, 2027
Enrollment
202 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy participants